Pharmaceutical Quality Management Software Market Size, Share and Trends 2026 to 2035
Pharmaceutical Quality Management Software Market (By Solution / Module Type: Document Management, Audit Management, CAPA (Corrective & Preventive Action) Management, Change Management, Supplier Quality Management, Non-Conformance / Deviation Management, Training Management, Risk & Compliance Management, Inspection Management, Other Quality Modules; By Deployment Mode: On-Premises Deployment, Cloud / Web-Based Deployment, Hybrid Deployment; By Enterprise Size: Large Enterprises, Medium Enterprises, Small & Emerging Pharma / Biotech; By End-User / Application Sector: Pharmaceutical & Biotechnology Manufacturers, Contract Development & Manufacturing Organizations (CDMOs) / CMOs, Research & Development (R&D) Organizations, Generic Drug Manufacturers, Regulatory / Compliance Authorities) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035
Get a Sample
Table Of Content
What is Pharmaceutical Quality Management Software Market Size?
The global pharmaceutical quality management software market size is calculated at USD 2.35 billion in 2025 and is predicted to increase from USD 2.66 billion in 2026 to approximately USD 8.03 billion by 2034, expanding at a CAGR of 13.07% from 2026 to 2035. The market is witnessing market expansion is primarily driven by rising research & development investments, increasing healthcare demands from an aging population, pressure to meet stringent regulatory standards, and the incorporation of advanced technologies like AI, ML, and robotics.
Market Highlights
- North America accounted for the largest market share of 40% in 2025.
- Asia Pacific is expected to grow at the fastest CAGR 18% between 2026 to 2036.
- By solution/module type, the CAPA (corrective & preventive action) management segment contributed the biggest market share of 30% in 2025.
- By solution/module type, the supplier quality management segment is growing at strong CAGR of 16% between 2026 to 2036.
- By deployment mode, the cloud/web-based segment captured the biggest market share of 60% in 2025 and is projected to maintain growth with a CAGR of 18% between 2026 to 2036.
- By enterprise size, the large enterprises segment accounted for the highest market share of 62% in 2025.
- By enterprise size, the medium enterprises segment is expanding at a healthy CAGR of 15% between 2026 to 2036.
- By end-user/application sector, the pharmaceutical & biotechnology manufacturers segment led with around 45% of market share in 2025.
- By end-user/application sector, the contract development and manufacturing organizations (CDMOs/CMOs) segment is growing at a notable CAGR of 17% between 2026 to 2036.
What is Pharmaceutical Quality Management Software?
The global pharmaceutical quality management software market comprises enterprise software solutions and services designed specifically to manage, monitor, automate, and improve quality-management processes in pharmaceutical and biotech manufacturing, R&D, and supply chain operations. These systems include modules such as document control, audit management, corrective and preventive actions, change control, non-conformance/deviation management, supplier quality management, training management, risk & compliance management, and quality analytics. They may be deployed on-premises or via cloud platforms, and they are critical for ensuring regulatory compliance and product quality.
How Can AI Impact the Pharmaceutical Quality Management Software Market?
Artificial intelligence (AI) is transforming the pharmaceutical quality management software market and enhancing efficiency and compliance through predictive analytics , automated documentation, real-time monitoring, and smart audit trails. AI tools can automatically analyze audit trails to find compliance issues faster, aiding in regulatory inspections. Also, AI provides risk scores for processes, products, and suppliers, helping companies focus on the most critical risks. Thus, AI-powered systems perform real-time visual inspections of products, ensuring consistency and catching defects.
Pharmaceutical Quality Management Software Market Outlook
[[market_outlook]]
Market Scope
| Report Coverage | Details |
| Market Size in 2025 | USD 2.35 Billion |
| Market Size in 2026 | USD 2.66 Billion |
| Market Size by 2035 | USD 8.03 Billion |
| Market Growth Rate from 2026 to 2035 | CAGR of 13.07% |
| Dominating Region | North America |
| Fastest Growing Region | Asia Pacific |
| Base Year | 2025 |
| Forecast Period | 2026 to 2035 |
| Segments Covered | Solution / Module Type, Deployment Mode, Enterprise Size, End-User / Application Sector, and region |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Pharmaceutical Quality Management Software MarketSegment Insights
[[segment_insights]]
Pharmaceutical Quality Management Software MarketRegional Insights
[[regional_insights]]
Pharmaceutical Quality Management Software Market Value Chain
[[value_chain]]
Pharmaceutical Quality Management Software Market Companies
[[market_company]]
Leaders' Announcements
- In March 2025, MasterControl announced acquisition of Qualer. This acquisition accelerates our vision of helping customers reduce complexity, increase efficiency, and speed time-to-market for life-changing products. Qualer will help us address a critical need in the industry by reducing costs, increasing productivity, and ensuring compliance for physical assets. (Source: https://www.prnewswire.com )
Recent Developments
- In February 2025, Yokogawa Electric Corporation launched the OpreX Quality Management System, a cutting-edge, cloud-based solution designed to accelerate digital transformation (DX) in quality assurance processes for pharmaceutical and food & beverage manufacturing industries. Ensures efficient, flexible, and error-free quality management by centralizing the management of deviations, CAPA (Corrective and Preventive Actions), changes in manufacturing procedures, and document revisions. (Source: https://www.biospectrumasia.com )
- In July 2024, Antares Vision Group launched DIAMIND Sentry, a solution allowing pharma companies to efficiently manage the substantial uptick in exceptions stemming from traceability mandates. The sophisticated system was developed by Rfxcel, a business unit of Antares Vision Group, providing supply chain visibility solutions. (Source: https://www.packagingtechtoday.com )
Pharmaceutical Quality Management Software MarketSegments Covered in the Report
[[segment_covered]]
For inquiries regarding discounts, bulk purchases, or customization requests, please contact us at sales@precedenceresearch.com
Frequently Asked Questions
Ask For Sample
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
.webp)
sales@precedenceresearch.com
+1 804-441-9344
Schedule a Meeting
